Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SRx Health Solutions (SRXH) Return on Sales (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Return on Sales for 13 consecutive years, with 0.53% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 66.0% year-over-year to 0.53%, compared with a TTM value of 0.53% through Sep 2025, down 32.0%, and an annual FY2024 reading of 0.33%, up 92.0% over the prior year.
  • Return on Sales was 0.53% for Q3 2025 at SRx Health Solutions, up from 0.74% in the prior quarter.
  • Across five years, Return on Sales topped out at 2.25% in Q2 2021 and bottomed at 2.63% in Q4 2022.
  • Average Return on Sales over 5 years is 0.45%, with a median of 0.29% recorded in 2023.
  • The sharpest move saw Return on Sales surged 351bps in 2021, then plummeted -252bps in 2022.
  • Year by year, Return on Sales stood at 0.46% in 2021, then plummeted by -468bps to 2.63% in 2022, then grew by 2bps to 2.58% in 2023, then skyrocketed by 92bps to 0.21% in 2024, then plummeted by -153bps to 0.53% in 2025.
  • Business Quant data shows Return on Sales for SRXH at 0.53% in Q3 2025, 0.74% in Q2 2025, and 0.13% in Q1 2025.